Evaluation of potential punishing effects of 2,5-dimethoxy-4-methylamphetamine (DOM) in rhesus monkeys responding under a choice procedure.
Behavioural Pharmacology October 1, 2024 DOI: 10.1097/fbp.0000000000000787 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Within-subjects experimental study Peer reviewed |
|---|---|
| Sample size | 4 |
| Population | Rhesus monkeys |
| Interventions | 2 5-dimethoxy-4-methylamphetamine (DOM) fentanyl histamine |
| Dose | 3.2-100 µg/kg/infusion for DOM and histamine; 0.1-3.2 µg/kg/infusion for fentanyl |
| Citations | 2 |
| Key findings | The 5-HT2A receptor agonist DOM had neither positive reinforcing nor punishing effects in a choice procedure with rhesus monkeys. |
Abstract
There has been substantial and growing interest in the therapeutic utility of drugs acting at serotonin 2A subtype (5-HT 2A ) receptors, increasing the need for characterization of potential beneficial and adverse effects of such compounds. Although numerous studies have evaluated the possible rewarding and reinforcing effects of 5-HT 2A receptor agonists, there have been relatively few studies on potential aversive effects. The current study investigated punishing effects of 2,5-dimethoxy-4-methylamphetamine (DOM) in four rhesus monkeys responding under a choice procedure in which responding on one lever delivered a sucrose pellet alone and responding on the other lever delivered a sucrose pellet plus an intravenous infusion of a range of doses of fentanyl (0.1-3.2 µg/kg/infusion), histamine (3.2-100 µg/kg/infusion), or DOM (3.2-100 µg/kg/infusion). When fentanyl was available, responding for a pellet plus an infusion increased dose dependently in all subjects, indicating a positive reinforcing effect of fentanyl. When histamine was available, responding for a pellet plus an infusion decreased in three of four subjects, indicating a punishing effect of histamine. Whether available before or after histamine, DOM did not systematically alter choice across the range of doses tested. These results suggest that the 5-HT 2A receptor agonist DOM has neither positive reinforcing nor punishing effects under a choice procedure that is sensitive to both processes.
Citations in the library
Cited by 3
- The utility of 2,5-dimethoxy-4-iodoamphetamine for the study of serotonin 2A and 2C receptors. Molecular Pharmacology 2026
- Next-Generation Psychedelic Drug Development ACS Chemical Neuroscience September 15, 2026
- Interactions between fentanyl and 2,5-dimethoxy-4-methylamphetamine: Ventilatory effects in nonhuman primates. Journal of Pharmacology and Experimental Therapeutics October 1, 2025
Cites 16
- The abuse potential of medical psilocybin according to the 8 factors of the Controlled Substances Act Neuropharmacology June 5, 2018
- Correlation between the potency of hallucinogens in the mouse head-twitch response assay and their behavioral and subjective effects in other species. Neuropharmacology May 1, 2020
- 2,5-Dimethoxy-4-methyl-amphetamine (STP): A New Hallucinogenic Drug Science November 3, 1967
- Transient reinforcing effects of phenylisopropylamine and indolealkylamine hallucinogens in rhesus monkeys Behavioural Pharmacology March 1, 2004
- Psychedelics therapeutics: What we know, what we think, and what we need to research. Neuropharmacology September 27, 2022
and 11 more in the library